Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

By Fang Yong   Hu Yi   Wu Peng   Wang Beibei   Tian Yuan   Xia Xi   Zhang Qinghua   Chen Tong   Jiang Xuefeng   Ma Quanfu   Xu Gang   Wang Shixuan   Zhou Jianfeng   Ma Ding   Meng Li  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite

The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib

By Yerlikaya Azmi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1385-1392

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

By Mortenson Melinda   Schlieman Michael   Virudachalam Subbulakshmi   Bold Richard  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 343-353

Springer Publishing Company

Access to resources Recommend Favorite

Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines

By Miyamoto Yuichiro   Nakagawa Shunsuke   Wada-Hiraike Osamu   Seiki Takayuki   Tanikawa Michihiro   Hiraike Haruko   Sone Kenbun   Nagasaka Kazunori   Oda Katsutoshi   Kawana Kei   Nakagawa Keiichi   Fujii Tomoyuki   Yano Tetsu   Kozuma Shiro   Taketani Yuji  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 51-57

Spandidos Publications

Access to resources Recommend Favorite

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells

By                

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1603-1607

Spandidos Publications

Access to resources Recommend Favorite